Exemestane and Full blood count abnormal - a phase IV clinical study of FDA data

Summary:

Full blood count abnormal is reported as a side effect among people who take Exemestane (exemestane), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Ibrance, and have Breast cancer female.

The phase IV clinical study analyzes which people have Full blood count abnormal when taking Exemestane. It is created by eHealthMe based on reports of 13,876 people who have side effects when taking Exemestane from the FDA, and is updated regularly.

What is Exemestane?

Exemestane has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 14,038 Exemestane users. Check the latest studies of Exemestane.

What is Full blood count abnormal?

Full blood count abnormal is found to be associated with 628 drugs and 378 conditions by eHealthMe. Check the latest studies of Full blood count abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

13,876 people reported to have side effects when taking Exemestane.
Among them, 26 people (0.19%) have Full blood count abnormal.

Could Exemestane cause Full blood count abnormal?

Among these 26 people:

How long have people been on Exemestane when they have Full blood count abnormal? *

What is the gender of people who have Full blood count abnormal when taking Exemestane? *

female: 96 %
male: 4 %

What is the age of people who have Full blood count abnormal when taking Exemestane? *

What are other drugs people take besides Exemestane? *

Ibrance: 24 people, 92.31%
Crestor: 5 people, 19.23%
Gabapentin: 5 people, 19.23%
Vitamin D3: 5 people, 19.23%
Letrozole: 4 people, 15.38%
Oxycodone Hydrochloride: 3 people, 11.54%
Calcium: 3 people, 11.54%
Lamotrigine: 3 people, 11.54%
Lorazepam: 3 people, 11.54%
Losartan Potassium: 3 people, 11.54%

What are other side effects people have besides Full blood count abnormal? *

Fatigue (feeling of tiredness): 11 people, 42.31%
White Blood Cell Count Decreased: 10 people, 38.46%
Red Blood Cell Count Decreased: 8 people, 30.77%
Nausea (feeling of having an urge to vomit): 7 people, 26.92%
Hair Loss: 7 people, 26.92%
Stomatitis (inflammation of mucous membrane of mouth): 4 people, 15.38%
Diarrhea: 4 people, 15.38%
Neoplasm Progression (growth of tumour): 4 people, 15.38%
Swallowing Difficulty: 3 people, 11.54%
Stress And Anxiety: 3 people, 11.54%

What are the existing conditions these people have? *

Breast Cancer Female: 12 people, 46.15%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 11.54%
Night Sweats (sweating in night): 3 people, 11.54%
Insomnia (sleeplessness): 3 people, 11.54%
Neoplasm Malignant (cancer tumour): 2 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.85%
Reaction To Preservatives: 1 person, 3.85%
High Blood Cholesterol: 1 person, 3.85%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Exemestane and have Full blood count abnormal?

- Check whether Full blood count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exemestane:

Exemestane (14,038 reports)

Browse all side effects of Exemestane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Full blood count abnormal:

Full blood count abnormal (628 drugs)

Browse all the conditions that are associated with Full blood count abnormal:

Full blood count abnormal (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exemestane (the active ingredients of Exemestane) and Exemestane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.